Skip to content
Forest Global Training Partners
Home Services AI Governance AI Risk Encyclopedia Contact Us
AI Risk Encyclopedia AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Hallucinations
  3. Combatting Hallucination's in FDA's AI - Pharmaceutical…

AI Hallucinations July 11, 2025 · Pharmaceutical Executive

Combatting Hallucination's in FDA's AI - Pharmaceutical Executive

PE: How can FDA prevent hallucinations ? Botha: We can't have our AI do that when it comes to critical analysis of core ingredients and component ...

Read the original at Pharmaceutical Executive ↗

Topics
Hallucinations & FabricationHealthcare
Mentions
FDA
Tracked via
“AI hallucination”

Related articles

  • Can AI Accelerate Clinical Review at FDA? - Pharmaceutical Executive AI Hallucinations · Jul 24, 2025
  • Potential Risksof Relying on Open-AccessAIModels - Pharmaceutical Executive AI Risks · Feb 10, 2025
  • Preventing Bias in AI: Q&A with Michael Armstrong - Pharmaceutical Executive AI Hallucinations · Jun 21, 2024
  • Driving Field Excellence withAI-Enhanced Rep Support - Pharmaceutical Executive AI Hallucinations · Dec 18, 2024
  • The Reality of AI : Q&A with Shweta Maniar - Pharmaceutical Executive AI Hallucinations · Aug 18, 2025
  • Lunit's AI Technology to Power German Radiology Network - Pharmaceutical Executive AI Use Cases · May 08, 2025

AI Risk Encyclopedia is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact